04/07/2026
They can't do this! We need access to these vital medications. They are not optional. They are essential.
The PBAC will soon consider the future of PBS access to Ocrevus and Kesimpta, two of Australia's most widely used MS treatments. For many Australians living with MS, these treatments are an essential part of managing their condition.
Sharlene Brown, who lives with MS and is an Independent Director at MS Australia, shared why continued access matters:
"π΄π π ππππππ πππ£πππ π€ππ‘β ππ, πππ ππ π ππππππ π€βπ πππ£ππππ‘ππ ππ£πππ¦ πππ¦ πππ π΄π’π π‘πππππππ ππππππ‘ππ ππ¦ π‘βππ πππ πππ π, πΌ ππππ ππ‘ ππππππππππ¦ πππππππ’ππ‘ π‘π π’πππππ π‘πππ βππ€ π‘βπ πΊππ£πππππππ‘ πππ’ππ ππππ‘ππππππ‘π πππ π‘ππππ‘πππ πππππ π π‘π πππππππ‘ππππ π‘βππ‘ βππ£π π‘ππππ ππππππ πππ£ππ πππ πππππ£ππππ ππππ£ππ ππ’π‘πππππ πππ π π ππππ¦ ππππππ.
πβππ π π‘ππππ‘ππππ‘π πππ πππ‘ π ππ’π₯π’ππ¦. πβππ¦ πππ π‘βπ ππππ ππ π‘βππ’π ππππ ππ π΄π’π π‘πππππππ πππ ππππ π‘π ππππππ ππ π‘βπ π€ππππππππ, ππππ πππ π‘βπππ ππππππππ , ππππ‘ππππ’π‘π π‘π π‘βπππ πππππ’πππ‘πππ πππ πππππ‘πππ π‘βπππ ππππππππππππ."
Find out more about what's happening, what MS Australia is doing, and how you can support our advocacy efforts:
https://www.msaustralia.org.au/your-voice-your-story/